Investigation Overview
San Diego, Nov. 28, 2011 (Shareholders Foundation) -- Following a media report about a possible sale of Achillion Pharmaceuticals, Inc. an investigation on behalf of investors of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) concerning whether a potential takeover would be unfair for NASDAQ:ACHN stockholders and whether certain Achillion Pharmaceuticals directors breach their fiduciar...
You must register (for free) or login to view the entire investigation.